根据名称进行药物检索

Timoptic-XE Ocumeter与心源性休克

Timoptic-XE Ocumeter与心源性休克安全配伍检测的结果。

检测结果:

Timoptic-XE Ocumeter <> 心源性休克

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

利用眼貝塔-肾上腺素受体阻断剂(又名的β受体阻滞剂)被认为是可由制造商为被禁忌的患者心原性冲击。局部应用的β受体阻滞剂是有系统地吸收，有可能产生临床上的重大系统性影响，甚至在低或无法检测的血浆水平。在心脏组织中，β封锁导致减少在变力以及变时性活动，这可以进一步降低心脏出血压在这样的病人。

来源

Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255
"Product Information. Betoptic (betaxolol ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
"Product Information. Timoptic (timolol ophthalmic)." Merck & Co, Inc, West Point, PA.
"Product Information. OptiPranolol (metipranolol)." Bausch and Lomb, Tampa, FL.
Tirlapur VG, Evans PJ, Jones MK "Shock syndrome after acebutolol." Br J Clin Pract 40 (1986): 33-4
Edeki TI, He H, Wood AJ "Pharmacogenetic explanation for excessive B-blockade following timolol eye drops." JAMA 274 (1995): 1611-3
"Product Information. Betagan Liquifilm (levobunolol)." Allergan Inc, Irvine, CA.
Uusitalo RJ, Palkama A "Efficacy and safety of timolol pilocarpine combination drops in glaucoma patients." Acta Ophthalmol (Copenh) 72 (1994): 496-504
"Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.
Shiuey Y, Eisenberg MJ "Cardiovascular effects of commonly used ophthalmic medications." Clin Cardiol 19 (1996): 5-8
Kholeif M, Isles C "Profound hypotension after atenolol in severe hypertension." Br Med J 298 (1989): 161-2
"Product Information. Ocupress (carteolol ophthalmic)" Ciba Vision Ophthalmics, Duluth, GA.